These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 16028515

  • 1. [Experimentally determined safety and immunological activity of vaccine based on antigens isolated from Pseudomonas aeruginosa in medium K-4].
    Nuriddinova NR, Sheremet'ev NN, Ivanova LE, Garib FIu, Iskhakova KhI.
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (3):57-60. PubMed ID: 16028515
    [Abstract] [Full Text] [Related]

  • 2. [Pseudomonas aeruginosa vaccine on the basis of antigens isolated from the supernatant of culture media K-4].
    Nuriddinova NR, Ivanova LE, Sheremet'ev NN, Garib FIu.
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (4):40-3. PubMed ID: 12449697
    [Abstract] [Full Text] [Related]

  • 3. [Experimental study of the dynamics of the formation of protective antibodies to the antigens of the slime of Pseudomonas aeruginosa].
    Iushkova NA, Stanislavskiĭ ES, Landsman NM.
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):78-83. PubMed ID: 6405564
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Cell-free Pseudomonas vaccine. IV. Laboratory trials of the effectiveness of experimental Pseudomonas vaccines].
    Stanislavskiĭ ES, Joó I, Bulk VF, Zhvanetskaia MI, Mashilova GM.
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Oct; (10):25-9. PubMed ID: 6817559
    [Abstract] [Full Text] [Related]

  • 6. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
    Zaidi TS, Priebe GP, Pier GB.
    Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
    [Abstract] [Full Text] [Related]

  • 7. [Production and experimental testing of the polyvalency of corpuscular vaccine for the prevention of Pseudomonas aeruginosa infections II. Experimental testing of the immunogenicity of polyvalent corpuscular Pseudomonas aeruginosa vaccine].
    Moroz AF, Antsiferova NG, Radkevich SA, Mishina VS.
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):74-80. PubMed ID: 6800165
    [Abstract] [Full Text] [Related]

  • 8. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES, Lam JS.
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [Abstract] [Full Text] [Related]

  • 9. The epidemiology of Pseudomonas aeruginosa and the development of a polyvalent vaccine.
    Pranter W, Staerk J, Zellner R, Zwisler O.
    Prog Immunobiol Stand; 1971 Nov; 5():414-8. PubMed ID: 4633968
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Vaccines against Pseudomonas aeruginosa infection: 1. Experimental studies.
    Stanislavsky ES, Joo I, Mashilova GM, Boolk VF, Boltutsy LG, Zakgeim DA, Severtśova MK, Yedvabnaya LS, Gladus MA, Fatkhinurova TI.
    Vaccine; 1985 Jun; 3(2):128-36. PubMed ID: 3929491
    [Abstract] [Full Text] [Related]

  • 12. [Cell-free Pseudomonas vaccine. II. Isolation and immunological properties of protective antigens of Pseudomonas aeruginosa].
    Stanislavskiĭ ES, Palkina NA, Bulk VF, Zhvanetskaia MI, Chekan LV.
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (8):37-40. PubMed ID: 6797158
    [No Abstract] [Full Text] [Related]

  • 13. [Derivation and experimental evaluation of polyvalent corpuscular vaccine for prevention of infections caused by Pseudomonas aeruginosa. I. Development of polyvalent corpuscular vaccine].
    Moroz AF, Radkevich SA, Antsiferova NG, Brodinova NS.
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (8):44-9. PubMed ID: 6171956
    [No Abstract] [Full Text] [Related]

  • 14. [Antigenic properties of Pseudomonas aeruginosa anatoxin and the protective action of antitoxic anti-Pseudomonas aeruginosa serum].
    Podgornaia LG, Dziuban NF.
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jun; (6):67-9. PubMed ID: 3092510
    [Abstract] [Full Text] [Related]

  • 15. [Cell-free Pseudomonas vaccine: its immunochemical characteristics and immunogenicity].
    Bandman OA, Edvabnaia LS, Bulk VF, Zhvanetskaia MI, Mashilova GM.
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):44-7. PubMed ID: 3124416
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Evaluation of properties of Pseudomonas aeruginosa recombinant outer membrane protein F (OprF)].
    Zlygostev SA, Gataullin AG, Kaloshin AA, Mikhaĭlova NA, Zverev VV.
    Zh Mikrobiol Epidemiol Immunobiol; 2006 Nov; (7):43-7. PubMed ID: 17297879
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A new polyvalent pseudomonas vaccine.
    Merle P, Robbel L, Hungerer KD.
    Behring Inst Mitt; 1984 Nov; (76):113-20. PubMed ID: 6441560
    [Abstract] [Full Text] [Related]

  • 20. Experimental immunization with attenuated mutants of Pseudomonas aeruginosa.
    Syeklocha D.
    Can J Microbiol; 1973 May; 19(5):573-80. PubMed ID: 4196781
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.